Barry S. Skikne
Direktor/Vorstandsmitglied bei TVAX BIOM
Profil
Barry S.
Skikne is an Independent Director at TVAX Biomedical, Inc. He previously worked as the Director-Bone Marrow Transplantation Program at the University of Kansas from 1993 to 2007.
Dr. Skikne completed his undergraduate degree at the University of the Witwatersrand and holds a doctorate degree from the University of South Africa.
Aktive Positionen von Barry S. Skikne
| Unternehmen | Position | Beginn |
|---|---|---|
| TVAX BIOM | Direktor/Vorstandsmitglied | 01.12.2011 |
Ehemalige bekannte Positionen von Barry S. Skikne
| Unternehmen | Position | Ende |
|---|---|---|
| University of Kansas | Corporate Officer/Principal | 01.07.2007 |
Ausbildung von Barry S. Skikne
| University of the Witwatersrand | Undergraduate Degree |
| University of South Africa | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
